secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2025-08-18T23:59:59+00:00
Accession:  0001213900-25-077937
Event type: litigation
Sentiment:  negative
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive discloses securities class action over phosphate binder NDA statements
--------------------------------------------------------------------------------

- Lawsuit filed in U.S. District Court for Northern District of California against company and certain officers.
- Alleges violations of federal securities laws regarding public statements on NDA for oxylanthanum carbonate phosphate binder.
- Product targets hyperphosphatemia in chronic kidney disease patients on dialysis.
- Company believes claims are meritless and intends to vigorously defend the lawsuit.
- Lawsuit became known to company on August 15, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025077937/0001213900-25-077937-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025077937/ea0253753-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-077937

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer